Clinical Trial Update: Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials [NA]

View source ↗

Summary

This document reports on a completed study from Dana-Farber Cancer Institute investigating deep clinical trajectory modeling to improve accrual to cancer clinic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Cancer | NA | Status: COMPLETED